Ejal 40 Bio-Revitalizing Gel

Ejal 40 represents a new frontier in skin bio-revitalization. Instead of volumizing, it functions as a bio-rejuvenating treatment that actively restores the physiological functions and elasticity of the skin. The formula’s HA Matrix System contains an optimal medium molecular weight of 1200-1800 kDalton, which, once injected, triggers the natural regenerative mechanisms of the dermis by stimulating fibroblast cells.

This process rebuilds the extracellular matrix, promoting the synthesis of new collagen, elastin, and the skin’s own hyaluronic acid. It is an ideal treatment for addressing skin laxity, dehydration, and photo-aging, and serves as an excellent primer to improve dermal tissue quality before treatments with volumizing fillers.

Key Specifications & Certifications:

• Active Substance: Non Cross-Linked Hyaluronic Acid (HA)
• Concentration: 40mg/2ml
• Molecular Weight: 1200-1800 kDalton
• Manufacturer: Medixa
• Certifications: Medical Device CE 1984, UNI EN ISO 13485, GMP – UNI EN ISO 22716
• Pack Size: 1 x 2.0ml pre-filled, sterile syringe
• Included Needles: 2 x sterile 30G needles

Clinical Applications & Indications:

• Treatment of skin laxity and sagging on the face, neck, décolletage, and hands
• Reduction of fine lines and superficial wrinkles
• Restoration of skin hydration, tone, and elasticity
• Reversal of photo-aging and sun-induced skin damage
• Treatment of stretch marks
• Pre-treatment to improve skin quality before dermal filler procedures

Treatment Protocol & 4 BRP Technique:

For optimal results, Ejal 40 follows a structured protocol, often utilizing the innovative 4-Point Bio-Revitalization (4 BRP) technique for efficient delivery and minimal patient discomfort.

• Initial Phase: 3 treatments spaced one month apart.
• Maintenance Phase: Repeat the protocol every 6-8 months, depending on the patient’s skin condition and aging level.
• 4 BRP Application: Inject 0.25ml per point at 4 specific points on each side of the face. This technique minimizes the risk of bruising and ensures even diffusion of the product.

Clinical Evidence & Proven Efficacy:

Ejal 40 is supported by clinical data demonstrating its effectiveness in skin rejuvenation.

• Elasticity: 85% of users reported increased skin elasticity after 3 sessions.
• Wrinkle Reduction: A 70% reduction in the appearance of fine lines was observed within 2 months.
• Hydration: Visible improvement in skin hydration by 60% after 4 weeks.
• Global Recognition: Available in 62 countries with over 200,000 treatments performed worldwide.

Safety & Tolerability Profile:

Ejal 40 is generally well-tolerated. As with any injection-based procedure, minor side effects may occur but typically resolve quickly.

• Common Effects: Mild redness, swelling, or temporary bruising at the injection site, usually resolving within 24 hours.
• Contraindications: Not suitable for individuals under 18, pregnant or breastfeeding women, or those with known hypersensitivity to the components or autoimmune conditions. Always consult the package insert.

Frequently Asked Questions (FAQ)